Torno Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Torno Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$401K	–	74
2025 Q3	$401K	Buy	+10,000	New	+$376K	0.03%	60

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Torno Capital's AGIO Position: Q4 2025 in Review

Torno Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 2,500 shares — an estimated $100K sold.

Torno Capital first reported a position in AGIO in Q3 2025 and held it in 1 quarter. The position peaked at $100K in Q3 2025. 237 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

Torno Capital reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Torno Capital sold 2,500 Agios Pharmaceuticals shares in Q4 2025, an estimated $100K.
Torno Capital first reported a position in Agios Pharmaceuticals in Q3 2025 and held it in 1 quarter.
Torno Capital's Agios Pharmaceuticals position peaked at $100K in Q3 2025.
237 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Torno Capital's 13F filing for Q4 2025, filed 17 Feb 2026.